Rheumatic tricuspid valve diseases
Chapter 9:Diseases of the circulatory system
ICD-10 I07 is a used to indicate a diagnosis of rheumatic tricuspid valve diseases.
Rheumatic tricuspid valve diseases are a subset of rheumatic heart diseases characterized by inflammation and damage to the tricuspid valve, typically resulting from rheumatic fever, which is a complication of untreated streptococcal throat infections. Clinically, patients may present with symptoms such as fatigue, palpitations, and signs of heart failure, including edema and ascites. The tricuspid valve, located between the right atrium and right ventricle, plays a crucial role in maintaining unidirectional blood flow. Disease progression can lead to tricuspid regurgitation or stenosis, which can exacerbate right-sided heart failure. Diagnosis often involves echocardiography to assess valve morphology and function, alongside clinical evaluation and history of rheumatic fever. Other diagnostic considerations may include electrocardiograms and chest X-rays to evaluate heart size and function. Early identification and management are essential to prevent further cardiac complications.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I07 covers rheumatic tricuspid valve diseases, including tricuspid regurgitation and tricuspid stenosis resulting from rheumatic fever. It is important to document the history of rheumatic fever and any associated symptoms to support the diagnosis.
I07 should be used when the primary diagnosis is rheumatic disease affecting the tricuspid valve. If the condition is due to non-rheumatic causes, such as degenerative changes or infective endocarditis, other codes should be considered.
Documentation should include a detailed patient history of rheumatic fever, clinical findings, echocardiographic results, and any treatment plans. Clear evidence of valve dysfunction and its impact on the patient's health is crucial.
